266 / 320
670
47. Faulkner, C. M., Cox, H. L., & Williamson, J. C. (2005).
Unique aspects of antimicrobial use in older adults. Clinical
Infectious Diseases : an Official Publication of the Infectious
Diseases Society of America, 40(7), 997–1004. http://doi.
org/10.1086/428125.
48. Sujino MD, Y. (2014). Impact of hypoalbuminemia, frailty,
and body mass index on early prognosis in older patients (
≥
85
years) with ST-elevation myocardial infarction. Journal of
Cardiology, 1–6.
http://doi.org/10.1016/j.jjcc.2014.12.001.49. Jason A. Roberts, (2012). The Clinical Relevance of Plasma
Protein Binding Changes. Clinical Pharmacokinetics, 52(1),
1–8.
http://doi.org/10.1007/s40262-012-0018-5.50. Butler, J. M., & Begg, E. J. (2008). Free drug metabolic clearance
in elderly people. Clinical Pharmacokinetics, 47(5), 297–321.
http://doi.org/10.2165/00003088-200847050-00002.51. Gurevich, K. G. (2013). Effect of blood protein concentrations
on drug-dosing regimes: practical guidance. Theoretical
Biology & Medical Modelling, 10(1), 20. http://doi.
org/10.1186/1742-4682-10-20.
52. Pasina, L., Brucato, A. L., Falcone, C., Cucchi, E., Bresciani,
A., Sottocorno, M., et al. (2014). Medication non-adherence
among elderly patients newly discharged and receiving
polypharmacy. Drugs & Aging, 31(4), 283–289. http://doi.
org/10.1007/s40266-014-0163-7.
53. Hajjar, E. R. (2014). Clinical consequences of polypharmacy in
elderly. Expert Opinion on Drug Safety, 13(1), 57–65. http://
doi.org/10.1517/14740338.2013.827660.54. Marcum, Z. A., & Gellad, W. F. (2012). Medication adherence
to multidrug regimens. Clinics in Geriatric Medicine, 28(2),
287–300.
http://doi.org/10.1016/j.cger.2012.01.008.[REV. MED. CLIN. CONDES - 2016; 27(5) 660-670]